Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AstraZeneca To Outsource Drug Manufacturing | Contract Pharma

What are you searching for?

Sign in
Breaking News

AstraZeneca To Outsource Drug Manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca is planning to outsource all drug manufacturing activities within 10 years, according to a company statement. “Manufacturing for AstraZeneca is not a core activity,” said David Smith, AstraZeneca’s executive vice-president of operations. “AstraZeneca is about innovation and brand-building. There are lots of people and organizations that can manufacture better than we can,” Mr. Smith said.

Mr. Smith is leading restructuring initiatives in an effort to reduce costs and improve profitability before patent expirations on key drugs. According to Mr. Smith, the group plans to become strictly a research, development and marketing organization and the priority is to outsource all of the company’s API manufacturing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters